Ocean Bio-Chem Inc
NASDAQ:OBCI
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
US |
Ocean Bio-Chem Inc
NASDAQ:OBCI
|
123.9m USD | 12.1 | ||
US |
Procter & Gamble Co
NYSE:PG
|
391.9B USD | 20.3 | ||
US |
Colgate-Palmolive Co
NYSE:CL
|
77.2B USD | 20.2 | ||
US |
Kimberly-Clark Corp
NYSE:KMB
|
46B USD | 16.8 | ||
UK |
Reckitt Benckiser Group PLC
LSE:RKT
|
32.8B GBP | 11.5 | ||
DE |
Henkel AG & Co KGaA
XETRA:HEN3
|
34.6B EUR | 13.7 | ||
US |
Church & Dwight Co Inc
NYSE:CHD
|
26.2B USD | 26.2 | ||
JP |
Unicharm Corp
TSE:8113
|
2.9T JPY | 18.9 | ||
SE |
Essity AB (publ)
STO:ESSITY B
|
195B SEK | 12 | ||
US |
Clorox Co
NYSE:CLX
|
17.6B USD | 21 | ||
MX |
Kimberly-Clark de Mexico SAB de CV
BMV:KIMBERA
|
109.6B MXN | 8.7 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.